Skye Bioscience, Inc. Maintenance Costs (Deprecated 2018-01-31)
Skye Bioscience, Inc. (SKYE) reported Maintenance Costs (Deprecated 2018-01-31) of $14.24 thousand for the 3-month period ending 2014-07-31, per its 10-Q filed 2014-09-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MaintenanceCosts · last filed 2014-09-15
- Skye Bioscience, Inc. maintenance costs (deprecated 2018-01-31) for the quarter ending 2014-07-31 was $14.24K, a 25.36% decline year-over-year.
- Skye Bioscience, Inc. maintenance costs (deprecated 2018-01-31) for the quarter ending 2014-04-30 was $16.62K, a 23.07% decline year-over-year.
- Skye Bioscience, Inc. maintenance costs (deprecated 2018-01-31) for the quarter ending 2014-01-31 was $14.30K, a 45.61% increase year-over-year.
- Skye Bioscience, Inc. maintenance costs (deprecated 2018-01-31) for the quarter ending 2013-10-31 was $16.82K.
- Skye Bioscience, Inc. maintenance costs (deprecated 2018-01-31) for fiscal 2013 was $67.30K, a 16894.44% increase from fiscal 2012.
- Skye Bioscience, Inc. maintenance costs (deprecated 2018-01-31) for fiscal 2012 was $396.00.
| Period end | Maintenance Costs (Deprecated 2018-01-31) 3 month | Maintenance Costs (Deprecated 2018-01-31) 6 month | Maintenance Costs (Deprecated 2018-01-31) 9 month | Maintenance Costs (Deprecated 2018-01-31) 12 month | Maintenance Costs (Deprecated 2018-01-31) 25 month | Maintenance Costs (Deprecated 2018-01-31) 29 month |
|---|---|---|---|---|---|---|
| 2014-07-31 | $14.24K 10-Q · filed 2014-09-15 | $30.86K derived: sum of 2 quarters · filed 2014-09-15 | $45.16K 10-Q · filed 2014-09-15 | $61.97K derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2014-04-30 | $16.62K 10-Q · filed 2014-06-05 | $30.92K 10-Q · filed 2014-06-05 | $47.73K derived: sum of 3 quarters · filed 2014-06-05 | $66.81K derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2014-01-31 | $14.30K 10-Q · filed 2014-03-17 | $31.11K derived: sum of 2 quarters · filed 2014-03-17 | $50.19K derived: sum of 3 quarters · filed 2014-09-15 | $71.79K derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2013-10-31 | $16.82K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $35.89K derived: sum of 2 quarters · filed 2014-09-15 | $57.49K derived: sum of 3 quarters · filed 2014-09-15 | $67.30K 10-K · filed 2014-01-27 | ||
| 2013-07-31 | $19.08K 10-Q · filed 2014-09-15 | $40.68K derived: sum of 2 quarters · filed 2014-09-15 | $50.48K 10-Q · filed 2014-09-15 | $50.88K 10-Q · filed 2013-09-16 | ||
| 2013-04-30 | $21.60K 10-Q · filed 2014-06-05 | $31.41K 10-Q · filed 2014-06-05 | $31.80K 10-Q · filed 2013-06-27 | |||
| 2013-01-31 | $9.82K 10-Q · filed 2014-03-17 | |||||
| 2012-10-31 | $396.00 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |